Annual Accounts Payable
$1.34 M
+$1.20 M+901.57%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual accounts payable is $1.34 million, with the most recent change of +$1.20 million (+901.57%) on December 31, 2023.
- During the last 3 years, ALDX annual accounts payable has risen by +$956.50 thousand (+250.66%).
- ALDX annual accounts payable is now -56.15% below its all-time high of $3.05 million, reached on December 31, 2018.
Performance
ALDX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$186.90 K
-$67.50 K-26.53%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly accounts payable is $186.90 thousand, with the most recent change of -$67.50 thousand (-26.53%) on September 30, 2024.
- Over the past year, ALDX quarterly accounts payable has dropped by -$60.30 thousand (-24.39%).
- ALDX quarterly accounts payable is now -95.34% below its all-time high of $4.01 million, reached on March 31, 2019.
Performance
ALDX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ALDX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +901.6% | -24.4% |
| 3 y3 years | +250.7% | -60.1% |
| 5 y5 years | -56.1% | -67.3% |
ALDX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +901.6% | -92.3% | +39.9% |
| 5 y | 5-year | at high | +901.6% | -92.3% | +50.9% |
| alltime | all time | -56.1% | +5188.9% | -95.3% | +186.2% |
Aldeyra Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $186.90 K(-26.5%) |
| Jun 2024 | - | $254.40 K(-9.2%) |
| Mar 2024 | - | $280.30 K(-79.1%) |
| Dec 2023 | $1.34 M(+901.6%) | $1.34 M(+441.3%) |
| Sep 2023 | - | $247.20 K(-8.7%) |
| Jun 2023 | - | $270.80 K(-37.0%) |
| Mar 2023 | - | $429.70 K(+221.6%) |
| Dec 2022 | $133.60 K(-86.9%) | $133.60 K(-89.8%) |
| Sep 2022 | - | $1.31 M(+394.7%) |
| Jun 2022 | - | $264.20 K(-89.2%) |
| Mar 2022 | - | $2.44 M(+139.6%) |
| Dec 2021 | $1.02 M(+167.2%) | $1.02 M(+117.9%) |
| Sep 2021 | - | $467.90 K(-57.2%) |
| Jun 2021 | - | $1.09 M(+144.0%) |
| Mar 2021 | - | $448.60 K(+17.6%) |
| Dec 2020 | $381.60 K(-52.8%) | $381.60 K(+208.0%) |
| Sep 2020 | - | $123.90 K(-42.8%) |
| Jun 2020 | - | $216.70 K(-79.8%) |
| Mar 2020 | - | $1.07 M(+32.7%) |
| Dec 2019 | $808.30 K(-73.5%) | $808.30 K(+41.2%) |
| Sep 2019 | - | $572.40 K(-79.4%) |
| Jun 2019 | - | $2.77 M(-30.9%) |
| Mar 2019 | - | $4.01 M(+31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.05 M(+204.9%) | $3.05 M(-11.3%) |
| Sep 2018 | - | $3.44 M(+329.2%) |
| Jun 2018 | - | $802.10 K(-50.5%) |
| Mar 2018 | - | $1.62 M(+61.7%) |
| Dec 2017 | $1.00 M(+263.5%) | $1.00 M(+106.3%) |
| Sep 2017 | - | $485.30 K(-36.4%) |
| Jun 2017 | - | $762.70 K(+9.8%) |
| Mar 2017 | - | $694.90 K(+152.3%) |
| Dec 2016 | $275.40 K(-67.6%) | $275.40 K(-62.5%) |
| Sep 2016 | - | $733.60 K(-10.9%) |
| Jun 2016 | - | $823.30 K(+42.4%) |
| Mar 2016 | - | $578.00 K(-32.1%) |
| Dec 2015 | $851.20 K(+149.4%) | $851.20 K(+14.5%) |
| Sep 2015 | - | $743.60 K(+18.2%) |
| Jun 2015 | - | $629.30 K(+55.0%) |
| Mar 2015 | - | $406.10 K(+19.0%) |
| Dec 2014 | $341.30 K(-0.2%) | $341.30 K(-29.3%) |
| Sep 2014 | - | $482.50 K(-13.2%) |
| Jun 2014 | - | $556.10 K(+235.0%) |
| Mar 2014 | - | $166.00 K(-51.4%) |
| Dec 2013 | $341.90 K(+371.6%) | $341.90 K(+423.6%) |
| Sep 2013 | - | $65.30 K(-9.9%) |
| Dec 2012 | $72.50 K(+186.6%) | $72.50 K |
| Dec 2011 | $25.30 K | - |
FAQ
- What is Aldeyra Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual accounts payable year-on-year change?
- What is Aldeyra Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly accounts payable year-on-year change?
What is Aldeyra Therapeutics annual accounts payable?
The current annual accounts payable of ALDX is $1.34 M
What is the all time high annual accounts payable for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual accounts payable is $3.05 M
What is Aldeyra Therapeutics annual accounts payable year-on-year change?
Over the past year, ALDX annual accounts payable has changed by +$1.20 M (+901.57%)
What is Aldeyra Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ALDX is $186.90 K
What is the all time high quarterly accounts payable for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly accounts payable is $4.01 M
What is Aldeyra Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ALDX quarterly accounts payable has changed by -$60.30 K (-24.39%)